Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

There are no files associated with this record.

Title Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial
Author Sjølie, Anne Katrin; Klein, Ronald; Porta, Massimo; Orchard, Trevor; Parving, Hans Henrik; Bilous, Rudy; Chaturvedi, Nish; Fox, Ywonne; Fuller, John; George, Michael; Svensson, Anders; Hainer, James; Klein, Ronald; Orchard, Trevor; Parving, Hans-Henrik; Porta, Massimo; Warnold, Ingrid; Agardh, Carl-David; Bonnici, Francois; Charbonnel, Bernard; Cooper, Mark; Dedov, Ivan; Gardiner, Robert; Davoren, Peter Michael; et al.
Year Published 2008
Publisher The Lancet Publishing Group
Citation Lancet, Vol. 372, pp. 1385-1393
Peer Reviewed Yes
Published Yes
Publisher URI http://www.thelancet.com/
Alternative URI http://dx.doi.org/10.1016/S0140-6736(08)61411-7
Faculty Griffith Health Faculty
Publication Type Journal Articles (Refereed Article)

Show full item record

Griffith University copyright notice